Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Multi-chaperone function modulation and association with cytoskeletal proteins are key features of the function of AIP in the pituitary gland.

Hernández-Ramírez LC, Morgan RML, Barry S, D'Acquisto F, Prodromou C, Korbonits M.

Oncotarget. 2018 Jan 11;9(10):9177-9198. doi: 10.18632/oncotarget.24183. eCollection 2018 Feb 6.

2.

Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic mice.

Balandaram G, Kramer LR, Kang BH, Murray IA, Perdew GH, Gonzalez FJ, Peters JM.

Toxicology. 2016 Jul 1;363-364:1-9. doi: 10.1016/j.tox.2016.07.010. Epub 2016 Jul 15.

3.

Cross-Tissue Regulatory Gene Networks in Coronary Artery Disease.

Talukdar HA, Foroughi Asl H, Jain RK, Ermel R, Ruusalepp A, Franzén O, Kidd BA, Readhead B, Giannarelli C, Kovacic JC, Ivert T, Dudley JT, Civelek M, Lusis AJ, Schadt EE, Skogsberg J, Michoel T, Björkegren JL.

Cell Syst. 2016 Mar 23;2(3):196-208. doi: 10.1016/j.cels.2016.02.002. Epub 2016 Mar 3.

4.

Adipogenesis is under surveillance of Hsp90 and the high molecular weight Immunophilin FKBP51.

Toneatto J, Charó NL, Galigniana NM, Piwien-Pilipuk G.

Adipocyte. 2015 May 13;4(4):239-47. doi: 10.1080/21623945.2015.1049401. eCollection 2015 Oct-Dec. Review.

5.

FKBP51 reciprocally regulates GRα and PPARγ activation via the Akt-p38 pathway.

Stechschulte LA, Hinds TD Jr, Ghanem SS, Shou W, Najjar SM, Sanchez ER.

Mol Endocrinol. 2014 Aug;28(8):1254-64. doi: 10.1210/me.2014-1023. Epub 2014 Jun 16.

6.

Ligand-regulated heterodimerization of peroxisome proliferator-activated receptor α with liver X receptor α.

Balanarasimha M, Davis AM, Soman FL, Rider SD Jr, Hostetler HA.

Biochemistry. 2014 Apr 29;53(16):2632-43. doi: 10.1021/bi401679y. Epub 2014 Apr 17.

7.

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Godoy P, Hewitt NJ, Albrecht U, Andersen ME, Ansari N, Bhattacharya S, Bode JG, Bolleyn J, Borner C, Böttger J, Braeuning A, Budinsky RA, Burkhardt B, Cameron NR, Camussi G, Cho CS, Choi YJ, Craig Rowlands J, Dahmen U, Damm G, Dirsch O, Donato MT, Dong J, Dooley S, Drasdo D, Eakins R, Ferreira KS, Fonsato V, Fraczek J, Gebhardt R, Gibson A, Glanemann M, Goldring CE, Gómez-Lechón MJ, Groothuis GM, Gustavsson L, Guyot C, Hallifax D, Hammad S, Hayward A, Häussinger D, Hellerbrand C, Hewitt P, Hoehme S, Holzhütter HG, Houston JB, Hrach J, Ito K, Jaeschke H, Keitel V, Kelm JM, Kevin Park B, Kordes C, Kullak-Ublick GA, LeCluyse EL, Lu P, Luebke-Wheeler J, Lutz A, Maltman DJ, Matz-Soja M, McMullen P, Merfort I, Messner S, Meyer C, Mwinyi J, Naisbitt DJ, Nussler AK, Olinga P, Pampaloni F, Pi J, Pluta L, Przyborski SA, Ramachandran A, Rogiers V, Rowe C, Schelcher C, Schmich K, Schwarz M, Singh B, Stelzer EH, Stieger B, Stöber R, Sugiyama Y, Tetta C, Thasler WE, Vanhaecke T, Vinken M, Weiss TS, Widera A, Woods CG, Xu JJ, Yarborough KM, Hengstler JG.

Arch Toxicol. 2013 Aug;87(8):1315-530. doi: 10.1007/s00204-013-1078-5. Epub 2013 Aug 23. Review.

8.

Regulation of TAK1/TAB1-mediated IL-1β signaling by cytoplasmic PPARβ/δ.

Stockert J, Wolf A, Kaddatz K, Schnitzer E, Finkernagel F, Meissner W, Müller-Brüsselbach S, Kracht M, Müller R.

PLoS One. 2013 Apr 30;8(4):e63011. doi: 10.1371/journal.pone.0063011. Print 2013.

9.

Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Beckers A, Aaltonen LA, Daly AF, Karhu A.

Endocr Rev. 2013 Apr;34(2):239-77. doi: 10.1210/er.2012-1013. Epub 2013 Jan 31. Review.

10.

Chaperoning steroidal physiology: lessons from mouse genetic models of Hsp90 and its cochaperones.

Sanchez ER.

Biochim Biophys Acta. 2012 Mar;1823(3):722-9. doi: 10.1016/j.bbamcr.2011.11.006. Epub 2011 Dec 4. Review.

11.

Protein phosphatase 5 mediates lipid metabolism through reciprocal control of glucocorticoid receptor and peroxisome proliferator-activated receptor-γ (PPARγ).

Hinds TD Jr, Stechschulte LA, Cash HA, Whisler D, Banerjee A, Yong W, Khuder SS, Kaw MK, Shou W, Najjar SM, Sanchez ER.

J Biol Chem. 2011 Dec 16;286(50):42911-22. doi: 10.1074/jbc.M111.311662. Epub 2011 Oct 12.

12.

The immunophilin-like protein XAP2 is a negative regulator of estrogen signaling through interaction with estrogen receptor α.

Cai W, Kramarova TV, Berg P, Korbonits M, Pongratz I.

PLoS One. 2011;6(10):e25201. doi: 10.1371/journal.pone.0025201. Epub 2011 Oct 3.

13.

Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.

Serrano-Marco L, Rodríguez-Calvo R, El Kochairi I, Palomer X, Michalik L, Wahli W, Vázquez-Carrera M.

Diabetes. 2011 Jul;60(7):1990-9. doi: 10.2337/db10-0704. Epub 2011 May 26.

14.

Regulation of Immune Responses and Autoimmune Encephalomyelitis by PPARs.

Yang Y, Lovett-Racke AE, Racke MK.

PPAR Res. 2010;2010:104705. doi: 10.1155/2010/104705. Epub 2010 Dec 22.

15.

Concomitant deletions of tumor suppressor genes MEN1 and AIP are essential for the pathogenesis of the brown fat tumor hibernoma.

Nord KH, Magnusson L, Isaksson M, Nilsson J, Lilljebjörn H, Domanski HA, Kindblom LG, Mandahl N, Mertens F.

Proc Natl Acad Sci U S A. 2010 Dec 7;107(49):21122-7. doi: 10.1073/pnas.1013512107. Epub 2010 Nov 15.

16.

Differential impact of tetratricopeptide repeat proteins on the steroid hormone receptors.

Schülke JP, Wochnik GM, Lang-Rollin I, Gassen NC, Knapp RT, Berning B, Yassouridis A, Rein T.

PLoS One. 2010 Jul 22;5(7):e11717. doi: 10.1371/journal.pone.0011717.

17.

The expression of AIP-related molecules in elucidation of cellular pathways in pituitary adenomas.

Heliövaara E, Raitila A, Launonen V, Paetau A, Arola J, Lehtonen H, Sane T, Weil RJ, Vierimaa O, Salmela P, Tuppurainen K, Mäkinen M, Aaltonen LA, Karhu A.

Am J Pathol. 2009 Dec;175(6):2501-7. doi: 10.2353/ajpath.2009.081131. Epub 2009 Oct 22.

18.

G-protein signalling negatively regulates the stability of aryl hydrocarbon receptor.

Nakata A, Urano D, Fujii-Kuriyama Y, Mizuno N, Tago K, Itoh H.

EMBO Rep. 2009 Jun;10(6):622-8. doi: 10.1038/embor.2009.35. Epub 2009 Apr 24.

19.

The PPARgamma2 A/B-domain plays a gene-specific role in transactivation and cofactor recruitment.

Bugge A, Grøntved L, Aagaard MM, Borup R, Mandrup S.

Mol Endocrinol. 2009 Jun;23(6):794-808. doi: 10.1210/me.2008-0236. Epub 2009 Mar 12.

20.

The glucagon receptor is required for the adaptive metabolic response to fasting.

Longuet C, Sinclair EM, Maida A, Baggio LL, Maziarz M, Charron MJ, Drucker DJ.

Cell Metab. 2008 Nov;8(5):359-71. doi: 10.1016/j.cmet.2008.09.008.

Supplemental Content

Support Center